GENEVA, March 10 -- RENAGADE THERAPEUTICS MANAGEMENT INC. (640 Memorial Drive, Suite 2300Cambridge, Massachusetts 02139) filed a patent application (PCT/US2024/044744) for "GENE EDITING SYSTEMS, COMPOSITIONS, AND METHODS FOR TREATMENT OF VEXAS SYNDROME" on Aug 30, 2024. With publication no. WO/2025/049959, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JOHN, Shinu (c/o ReNAgade Therapeutics Management Inc.640 Memorial Drive, Suite 2300Cambridge, Massachusetts 02139), LAYER, Jacob (c/o ReNAgade Therapeutics Management Inc...